Skip to main content
SpringerLink
Log in

The role of fibroblasts in tumor behavior

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

The prominent desmoplastic or stromal reaction seen in many invasive carcinomas suggests that stromal cells play a role in cancer pathogenesis. Investigations based on cell typing, using antibodies to cytoskeletal constituents, have revealed that most tumors contain various types of fibroblasts. Stromal cells with myofibroblastic differentiation features are the predominant cell type at the periphery of epithelial tumors. These tumoractivated fibroblasts play a major role in tumor development and spread, affecting the proliferation, differentiation, invasion or regression of cancer cells. This review considers the events inducing the different fibroblastic responses and the role of tumor-activated fibroblasts in both tumor development and anti-cancer treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Starkey JR: Cell-matrix interactions during tumor invasion. Cancer Metast Rev 9: 113–123, 1990

    Google Scholar 

  2. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 315: 1650–1659, 1986

    Google Scholar 

  3. Barr LC, Carter RL, Davies AJS: Encapsulation of tumours as a modified wound healing response. Lancet 1: 135–137, 1988

    Google Scholar 

  4. Darby I, Skalli O, Gabbiani G: α-smooth-muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63: 21–29, 1990

    Google Scholar 

  5. Gabbiani G, Ryan GB, Majno G: Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27: 549–550, 1971

    Google Scholar 

  6. Desmoulière AH, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146: 56–66, 1995

    Google Scholar 

  7. Gabbert H: Mechanisms of tumor invasion: evidence fromin vivo observations. Cancer Metast Rev 3: 257–279, 1985

    Google Scholar 

  8. Pauli UP, Knudson W: Tumor invasion: a consequence of destructive and compositional matrix alterations. Hum Pathol 19: 628–639, 1988

    Google Scholar 

  9. Dingemans KP, Zeeman-Boeschoten IM, Keep RF, Das PK: Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer 54: 1010–1016, 1993

    Google Scholar 

  10. Schmitt-Gräff A, Desmoulière A, Gabbiani G: Heterogeneity of myofibroblast phenotypic features an example of fibroblastic cell plasticity. Virchows Arch 425: 3–24, 1994

    Google Scholar 

  11. Rønnov-Jenssen L, Petersen OW: Induction of alphasmooth muscle actin by transforming growth factor beta 1 in quiescent human breast gland fibroblasts. Implication for myofibroblast generation in breast neoplasia. Lab Invest 68: 696–707, 1993

    Google Scholar 

  12. Rønnov-Jenssen L, Petersen OW, Koteliansky VE, Bissell MJ: The origin of the myofibroblasts in breast cancer: recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95: 859–873, 1995

    Google Scholar 

  13. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE: Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90: 999–1003, 1993

    Google Scholar 

  14. Ohtani H, Sasano N: Stromal cell changes in human colorectal adenomas and carcinomas. Virchows Arch (Pathol Anat) 401: 209–222, 1983

    Google Scholar 

  15. Hewitt RE, Powe DG, Carter GI, Turner DR: Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer 53: 62–69, 1993

    Google Scholar 

  16. Lieubeau B, Garrigue L, Barbieux I, Meflah K, Grégoire M: The role of transforming growth factor β1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 54: 6526–6532, 1994

    Google Scholar 

  17. Tsukamoto H, Mishima Y, Hayashibe K, Sasase A: Alphasmooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. J Invest Dermatol 98: 116–120, 1992

    Google Scholar 

  18. Carr I: The invasive edge: invasion in colorectal cancer. Clin Exp Metast 4: 129–139, 1986

    Google Scholar 

  19. Mareel M, Van Roy FM, De Baetselier PD: The invasive phenotypes. Cancer Metast Rev 9: 45–62, 1990

    Google Scholar 

  20. Sappino AP, Schürch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63: 144–161, 1990

    Google Scholar 

  21. Babij P, Zhao J, White S, Woodcock-Mitchell J, Mitchell J, Absher M, Baldor L, Periasamy M, Low RB: Smooth muscle myosin regulation by serum and cell density in culture rat lung connective tissue cells. Am J Physiol 265: L127–L132, 1993

    Google Scholar 

  22. Chiavegato A, Scatena M, Roelofs M, Ferrareses P, Pauletto P, Passerini-Glazel G, Pagano F, Sartore S: Cytoskeletal and cytocontractile protein composition of smooth muscle cells in developing and obstructed rabbit bladder. Exp Cell Res 207: 310–320, 1993

    Google Scholar 

  23. Vogetseder W, Feichtinger H, Schulz TF, Schwaevle W, Tabaczewski P, Mitterer M, Böck G, Marth C, Dapunt O, Mikuz G, Dierich MP: Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer 43: 768–773, 1989

    Google Scholar 

  24. Schulz TF, Mitterer M, Vogetseder W, Böck G, Myones B, Dierich MP: Identification and characterization of a novel membrane activation antigen with wide cellular distribution. Eur J Immunol 18: 7–11, 1988

    Google Scholar 

  25. Garin-Chesa P, Old LJ, Rettig WJ: Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA 87: 7235–7239, 1990

    Google Scholar 

  26. Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ, Rettig WJ: Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol 12: 1193–1203, 1994

    Google Scholar 

  27. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ: Molecular cloning of fibroblast activation alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 91: 5657–5661, 1994

    Google Scholar 

  28. Goustin AS, Leof EB, Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 46: 1015–1029, 1986

    Google Scholar 

  29. Maquart FX, Gillery P, Kalis B, Borel JP: Cytokines and fibrosis. Eur J Dermatol 4: 91–97, 1994

    Google Scholar 

  30. Bennet NT, Schultz GS: Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 165: 728–737, 1993

    Google Scholar 

  31. Kingsnorth AN, Slavin J: Peptide growth factors and wound healing. Br J Surg 78: 1286–1290, 1991

    Google Scholar 

  32. Herlyn M, Malkowicz SB: Regulatory pathways in tumor growth and invasion. Lab Invest 65: 262–271, 1991

    Google Scholar 

  33. Kovacs EJ, DiPietro LA: Fibrogenic cytokines and connective tissue production. FASEB J 8: 854–861, 1994

    Google Scholar 

  34. Sporn MB, Roberts AB: Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest 78: 329–332, 1986

    Google Scholar 

  35. Wahl SM, McCartney-Francis N, Mergenhagen SE: Inflammatory and immunomodulatory roles of TGFβ. Immunol Today 10: 258–261, 1989

    Google Scholar 

  36. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB: Distribution and modulation of the cellular receptor for transforming growth factor β. J Cell Biol 105: 965–975, 1987

    Google Scholar 

  37. Wakefield LM, Smith DM, Flanders KC, Sporn MB: Latent transforming growth factor β from human platelets: a high molecular weight complex containing precursor sequences. J Biol Chem 263: 7646–7654, 1988

    Google Scholar 

  38. Anzano MA, Rieman D, Pritchett W, Bowen-Pope DF, Greig R: Growth factor production by human colon carcinoma cell lines. Cancer Res 49: 2898–2904, 1989

    Google Scholar 

  39. Coffey RJ, Shipley GD, Moses HL: Production of transforming growth factors by human colon cancer lines. Cancer Res 46: 1164–1169, 1986

    Google Scholar 

  40. Levine AE, Macrare LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG: Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Cancer Res 45: 2248–2254, 1985

    Google Scholar 

  41. Grégoire M, Garrigue L, Blottière HM, Denis MG, Meflah K: Possible involvement of TGFβ1 in the distinct tumorigenic properties of two rat colon carcinoma clones. Invasion and metastasis 12: 185–196, 1992

    Google Scholar 

  42. Eklöv S, Funa K, Nordgren H, Olofson A, Kanzaki T, Miyazono K, Nilsson S: Lack of the latent transforming growth factor β binding protein in malignant, but not benign prostatic tissue. Cancer Res 53: 3193–3197, 1993

    Google Scholar 

  43. Gleave M, Hsieh J-T, Gao C, Von Escenbach AC, Chung LWK: Acceleration of human prostate cancer growthin vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51: 3753–3761, 1991

    Google Scholar 

  44. Steiner MT, Barrack ER: Transforming growth factor β1 overproduction in prostate cancer: effects on growthin viro andin vitro. Mol Endocrinol 6: 15–25, 1992

    Google Scholar 

  45. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH: Transforming growth factor β1 as a biomarker for prostate cancer. J Cell Biochem 16H: 54–61, 1992

    Google Scholar 

  46. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor β1 with prostate cancer: an immunohistochemical study. Hum Pathol 24: 4–9, 1993

    Google Scholar 

  47. Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM, Kasid A: Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factor α and β1 in renal cell carcinoma. Cancer Res 49: 6972–6975, 1989

    Google Scholar 

  48. Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S: Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 51: 4080–4083, 1991

    Google Scholar 

  49. Mooradian DL, McCarthy JB, Komanduri KV, Furcht LT: Effects of transforming Growth factor β1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasionin vitro. J Natl Cancer Inst 84: 523–527, 1992

    Google Scholar 

  50. Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L, Coombes RC: Localization of basic Fibroblast Growth Factor and Transforming Growth Factor β1 in the human mammary gland. Cancer Res 51: 4685–4692, 1991

    Google Scholar 

  51. Gorsch SM, Memoli VA, Strukel TA, Gold LI, Arrick BA: Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 52: 6949–6952, 1992

    Google Scholar 

  52. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB: Localization of transforming growth factor β isotypes in lesions of the human breast. Hum Pathol 23: 13–20, 1992

    Google Scholar 

  53. Walker RA, Dearing SJ: Transforming growth factor betal in ductal carcinomain situ and invasive carcinomas of the breast. Eur J Cancer 28: 641–644, 1992

    Google Scholar 

  54. Ethier SP, Van de Velde M: Secretion of TGFβ-like growth factor inhibitor by normal rat mammary epithelial cellsin vitro. J Cell Physiol 142: 15–20, 1990

    Google Scholar 

  55. Manning AM, Williams AC, Game SM, Paraskeva C: Differential sensitivity of human colonic adenoma and conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGFβ. Oncogene 6: 1471–1476, 1991

    Google Scholar 

  56. Reiss M, Stash EB: High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor β. Cancer Commun 2: 363–369, 1990

    Google Scholar 

  57. Kerbel RS, Theodorescu D: Tumor cell subpopulation interactions mediated by transforming growth factor β may contribute to clonal dominance of metastatically competent cells in primary tumors. In: Burger MM, Sordat B, Zinkernagel RM (eds) Cell to cell interaction. pp 100–113. Basel, Karger, 1990

    Google Scholar 

  58. Mulder KM, Ramey MK, Hoosein NM, Levin AE, Hinshaw XH, Brattain DE, Brattain MG: Characterization of transforming growth factor β resistant subclones isolated from a transforming growth factor sensitive human colon carcinoma cell line. Cancer Res 48: 7120–7125, 1988

    Google Scholar 

  59. Antonelli-Orlidge A, Saunders KB, Smith SR, d'Amore PA: An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86: 4544–4548, 1989

    Google Scholar 

  60. Roberts A, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesisin vivo and stimulation of collagen formationin vitro. Proc Natl Acad Sci USA 83: 4167–4171, 1986

    Google Scholar 

  61. Ueki N, Ohkawa T, Yokoyama Y, Maeda J, Kawai Y, Ikeda T, Amuro Y, Hada T, Higashino K: Potentiation of metastatic capacity by transforming growth factor β1 gene transfection. Jpn J Cancer Res 84: 589–593, 1993

    Google Scholar 

  62. Ebert EC, Roberts AI, O'Connel SM, Robertson FM, Nagase H: Characterization of an immunosuppressive factor derived from colon cancer cells. J Immunol 138: 2161–2168, 1987

    Google Scholar 

  63. Ellingsworth LR, Nakayama D, Segarini P, Dasch J, Carillo P, Waegell W: Transforming growth factor βs are equipotent growth inhibitors of IL1 induced thymocyte proliferation. Cell Immunol 114: 41–54, 1988

    Google Scholar 

  64. Guillou PJ, Ramsden CW, Somers SS, Sedman PC: Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants ofin vitro maintained tumour cell lines. Br J Cancer 59: 515–521, 1989

    Google Scholar 

  65. Guillou PJ, Sedman PC, Ramsden CW: Inhibition of lymphokine-activated killer cell generation by cultured tumor cell linesin vitro. Cancer Immunol Immunother 28: 43–53, 1989

    Google Scholar 

  66. Lucas C, Wallick S, Fendly BM, Figari I, Palladino MA: TGFβ: a possible autocrine immune regulator. Clinical applications of TGFβ. Wiley, Chichester (Ciba Foundation symposium 157): 98–114, 1991

    Google Scholar 

  67. Ruscetti F, Varesio L, Ochoa A, Ortaldo J: Pleiotropic effects of transforming growth factor β on cells of the immune system. Ann New York Acad Sci: 488–500, 1993

  68. Garrigue L, Lieubeau B, Barbieux I, Meflah K, Grégoire M: Implication of TGFβ1 in the stromal reaction to human colon tumours; Bull Cancer 80: 225–234, 1993

    Google Scholar 

  69. Ignotz RA, Endo T, Massague J: Regulation of fibronectin and type-I collagen mRNA levels by transforming growth factor β. J Biol Chem 262: 6443–6446, 1987

    Google Scholar 

  70. Ignotz RA, Massague J: Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337–4345, 1986

    Google Scholar 

  71. Raghow R, Postlewaite AE, Keski-Oja J, Moses HL, Kang AH: Transforming growth factor β increases steady state levels of type I procollagen and fibronectin messenger RNAs post-transcriptionally in cultured human dermal fibroblasts. J Clin Invest 79: 1285–1288, 1986

    Google Scholar 

  72. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor β1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103–111, 1993

    Google Scholar 

  73. Raghow R: Role of transforming growth factor-β and fibrosis. Chest 99: 61s-65s, 1991

    Google Scholar 

  74. Sieweke MH, Bissell MJ: The tumor-promoting effect of wounding: a possible role for TGFβ-induced stromal alterations. Critical Reviews of Oncogenesis 5: 297–311, 1994

    Google Scholar 

  75. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor β by proteoglycan decorin. Nature 346: 281–284, 1990

    Google Scholar 

  76. Hausser H, Gröning A, Hasilik A, Schönherr E, Kresse H: Selective inactivity of TGFβ/decorin complexes. FEBS letters 353: 243–245, 1994

    Google Scholar 

  77. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin C-H, Rifkin DB: Role of the latent TGFβ binding protein in the activation of latent TGFβ by cocultures of endothelial and smooth muscle cells. J Cell Biol 120: 995–1002, 1993

    Google Scholar 

  78. Miyazono K, Olofsson A, Colosetti P, Heldin C-H: A role of the latent TGFβ1-binding protein in the assembly and secretion of TGFβ1. Embo J 10: 1091–1101, 1991

    Google Scholar 

  79. Kanzaki T, Olofson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welch L, Heldin C-H: TGFβ1 binding protein: a component of the large latent complex of TGFβ1 with multiple repeat sequences. Cell 61: 1051–1061, 1990

    Google Scholar 

  80. Lamarre J, Wollenberg GK, Gonias SL, Hayes MA: Reaction of α2 macroglobulin with plasmin increases binding of transforming growth factors β1 and β2. Biochim Biophys Acta 1091: 197–204, 1990

    Google Scholar 

  81. Lamarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL: An α2 macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor β1 in mice. J Clin Invest 87: 39–44, 1989

    Google Scholar 

  82. McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FGP, Weksler BB: Transforming growth factor β activity is potentiated by heparin via dissociation of the transforming growth factor β/α2 macroglobulin inactive. J Cell Biol 109: 441–448, 1989

    Google Scholar 

  83. O'Connor-McCourt MD, Wakefield LM: Latent transforming growth factor α in serum. A specific complex with α2 macroglobulin. J Biol Chem 262: 14090–14099, 1987

    Google Scholar 

  84. Isaji M, Aruga N, Naito J, Miyata H: Inhibition by Tranilast of collagen accumulation in hypertensive granulomatous inflammationin vivo and of morphological changes and functions of fibroblastsin vitro. Life Sci 55: 287–292, 1994

    Google Scholar 

  85. Halvorsen TB, Seim E: Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 42: 162–166, 1989

    Google Scholar 

  86. Seemayer TA, Schürch W, Lagace R: Myofibroblasts in human pathology. Hum Pathol 12: 491–492, 1981

    Google Scholar 

  87. Lieubeau B, Garrigue-Antar L, Barbieux I, Meflah K, Grégoire M: Role of TGFβ1 in the stroma reaction associated with the rat colorectal tumour progression. J Exp Clin Cancer Res 14: 92–94, 1995

    Google Scholar 

  88. Vaage J, Harlos JP: Collagen production by macrophages in tumour encapsulation and dormancy. Br J Cancer 63: 758–762, 1991

    Google Scholar 

  89. Vaage J: Immunologic aspects of fibrosis in mouse mammary carcinomas. Int J Cancer 50: 69–74, 1992

    Google Scholar 

  90. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D: Modulation of tumor cell responses to chemotherapy by the organ environment. Cancer Metastasis Rev 13: 209–222, 1994

    Google Scholar 

  91. Marengo SR, Chung LW: An orthotopic model for the study of growth factors in the ventral prostate of the rat: effect of epidermal growth factor and basic fibroblast growth factor. J Androl 15: 277–286

  92. Yashiro M, Chung YS, Sowa M: Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 85: 883–893, 1994

    Google Scholar 

  93. Fabra A, Nakajima M, Bucana CD, Fidler IJ: Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblast in nude mice. Differentiation 52: 101–110, 1992

    Google Scholar 

  94. Cornil I, Theodorescu D, Mann S, Herlyn M, Jambrosic J, Kerbel RS: Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 88: 6028–6032, 1991

    Google Scholar 

  95. Miura S, Kodaira S, Hosoda Y: Immunohistologic analysis of the extracellular matrix components of the fibrous stroma of human colon cancer. J Surg Oncol 53: 36–42, 1993

    Google Scholar 

  96. Guidry C: Extracellular matrix contraction by fibroblasts: peptide promoters and second messengers. Cancer Met Rev 11: 45–54, 1992

    Google Scholar 

  97. Schürch W, Seemayer TA, Lagacé R: Stromal myofibroblasts in primary invasive and metastatic carcinomas. Virchows Arch (Pathol Anat) 391: 125–139, 1981

    Google Scholar 

  98. Vaage J, Pepin KG: Morphological observations during developing concomitant immunity against a C3H/He mammary tumor. Cancer Res 45: 659–666, 1985

    Google Scholar 

  99. Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890–1898, 1990

    Google Scholar 

  100. Paget S: Lancet 1: 571–573, 1889

    Google Scholar 

  101. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 948: 175–224, 1988

    Google Scholar 

  102. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P, Gespach C: Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 64: 70–75, 1995

    Google Scholar 

  103. Basset P, Wolf C, Rouger N, Bellocq JP, Rio MC, Chambon P: Stromelysin-3 in stromal tissue as a control in breast cancer behavior. Cancer 74: 1045–1049, 1994

    Google Scholar 

  104. Basset P, Wolf C, Chambon P: Expression of the stromelysin 3 gene in fibroblastic cells of invasive carcinoma of the breast and other human tissues: a review. Breast Cancer Res Treat 24: 185–193, 1993

    Google Scholar 

  105. Chiquet-Ehrismann R, Kalla P, Pearson CA: Participation of tenascin and transforming growth factor β in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res 49: 4322–4325, 1989

    Google Scholar 

  106. Sakai T, Kawakatsu H, Ohta M, Saito M: Tenascin induction in tenascin nonproducing carcinoma cell linesin vivo and by TGFβin vitro. J Cell Physiol 159: 561–572, 1994

    Google Scholar 

  107. Lane TF, Sage EH: The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8: 163–173, 1994

    Google Scholar 

  108. Pyke C, Ralfkiaer E, Tryggvason K, Dano K: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359–365, 1993

    Google Scholar 

  109. Stearms ME, Wang M: Type IV collagenase (Mr 72.000) expression in human prostate: benign and malignant tissues. Cancer Res 53: 878–883, 1993

    Google Scholar 

  110. Hewitt RE, Powe DG, Griffin NR, Turner DR: Relationships between epithelial basement membrane staining patterns in primary colorectal carcinomas and the extent of tumour spread. Int J Cancer 48: 855–860, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de Biologie, INSERM U419, 9 quai Moncousu, 44035, Nantes cedex, France

    Marc Grégoire & Blandine Lieubeau

Authors
  1. Marc Grégoire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Blandine Lieubeau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grégoire, M., Lieubeau, B. The role of fibroblasts in tumor behavior. Cancer Metast Rev 14, 339–350 (1995). https://doi.org/10.1007/BF00690602

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00690602

Key words

Search

Navigation